PEGADIGM Trademark

Trademark Overview


On Monday, April 9, 2007, a trademark application was filed for PEGADIGM with the United States Patent and Trademark Office. The USPTO has given the PEGADIGM trademark a serial number of 77151812. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, July 2, 2008. This trademark is owned by Pfizer Inc.. The PEGADIGM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of growth hormone deficiency and Prader-Willi Syndrome (PWS); pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and human growth hormones
pegadigm

General Information


Serial Number77151812
Word MarkPEGADIGM
Filing DateMonday, April 9, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, July 2, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2007

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of growth hormone deficiency and Prader-Willi Syndrome (PWS); pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and human growth hormones

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 12, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, September 2, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, September 2, 2008ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 1, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 9, 2007PUBLISHED FOR OPPOSITION
Wednesday, September 19, 2007NOTICE OF PUBLICATION
Saturday, September 1, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 31, 2007ASSIGNED TO LIE
Monday, July 23, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 23, 2007ASSIGNED TO EXAMINER
Thursday, April 12, 2007NEW APPLICATION ENTERED IN TRAM